Intel's Finally Paying Time: Should Investors Reconsider?
After years of setbacks, Intel appears to be turning a corner on its AI ambitions. This article breaks down what to w...
Which Investors Should Avoid Robo Advisors
Which Investors Should Avoid Robo Advisors outlines situations where automated options may underperform. This intro highlights alternatives to consider.
28,175 articles
The Artificial Intelligence (AI) Stock Upgrades in 2026
In 2026, one AI-focused stock has become the darling of bulls and analysts alike. This article dives into the reasons...
Atlanticus Unloads Million Shares: Should You Sell ATLC Too?
When a chief financial officer sells a large block of stock, investors sit up and take notice. This article breaks do...
What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Advisory Initiated Position Telephone: Is TDS a Buy?
A new institutional stake in Telephone and Data Systems has sparked questions about its implications. This guide expl...
Stellantis Trails Rival Metrics, Yet Offers Upside for Investors
Stellantis faces a tougher profitability and cash-flow comparison with its peers. But for patient investors, the long...
Is Quarterly Reporting Hurting Investors? SEC Weighs In
The SEC proposes letting companies use semiannual reports to meet interim disclosure duties, potentially easing burde...
Palmer Luckey Says Silicon Should Serve the People Now
Defense-tech pioneer Palmer Luckey calls for public-oversight over AI, arguing government power should guide how AI i...
Amazon Prime Returns June: Why It Matters to Investors Now
Prime Day returns this June with a four-day stretch that doubles the window for spending signals. Here’s how investor...
Should Gold After Correction Be a Buy? Insights From History
A 19% correction can spark questions about buying gold. This guide breaks down what history says, weighs physical gol...
Milestone Pharmaceuticals Stock Wilted: Midweek Decline
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
Molina Healthcare Stock Cruised to Strong Weekly Gains
Investors rotated into defensive names, helping Molina Healthcare stock cruised to near-a-10% weekly gain. Learn what...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status